Latest News
- January 25, 2012
Amorcyte, a NeoStem Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction - January 23, 2012
Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease - January 12, 2012
Islet Sciences, Inc. Selects NeoStem's Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
Feature Stories
- Interview with NeoStem Austin Customer
- Adam and Amy Domecq of Austin, Texas made the wise decision to choose NeoStem for the collection and banking of their adult stem cells for future medical use. The couple traveled to New York to ......
Adam and Amy Domecq of Austin, Texas
- New Developments in Cambridge
- During the past year, NeoStem made a major investment in its stem cell research and development capabilities. Important milestones include the expansion of the company’s laboratory infrast......
NeoStem's Cambridge Laboratory
Media Contact
Robin Smith, CEO
Phone: (212) 584-4174
Sign up to receive email alerts
Press Materials
Factsheet
Copyright © 2010 NeoStem, Inc.
Privacy Policy | Terms of Use | Social Media Policy | Site Map | Contact Us
Members of the NeoStem Family
